Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections

Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)

NCT04332094 ·Status: UNKNOWN ·Phase: PHASE2

A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

NCT00002140 ·Status: COMPLETED ·Phase: PHASE3

TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).

NCT00449644 ·Status: COMPLETED ·Phase: PHASE2

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

NCT04677543 ·Status: COMPLETED ·Phase: PHASE3

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

NCT05824988 ·Status: RECRUITING

The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis

NCT05664568 ·Status: UNKNOWN ·Phase: PHASE2

Toxicity of Treatments for Non-tuberculous Mycobacterial Infections in Cancer Patients or Not

NCT05030701 ·Status: UNKNOWN

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)

NCT04630145 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection

NCT07228702 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

NCT07213765 ·Status: RECRUITING ·Phase: PHASE4

Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Participants

NCT04301310 ·Status: WITHDRAWN ·Phase: PHASE1

Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection

NCT03421743 ·Status: COMPLETED ·Phase: PHASE2

Antibiotics Use and Carriage of Methicillin-resistant Staphylococci in Community Patients

NCT01489878 ·Status: COMPLETED

Rickettsia Clearance Study

NCT05972772 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis

NCT00523926 ·Status: COMPLETED ·Phase: PHASE2

A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections

NCT02355015 ·Status: UNKNOWN

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

NCT05382312 ·Status: COMPLETED ·Phase: PHASE2

Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis

NCT01169038 ·Status: COMPLETED ·Phase: PHASE1

Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

NCT01521364 ·Status: COMPLETED ·Phase: PHASE4

Rapid Identification of Mycobacteria in Acid-fast Bacilli Smear-positive Respiratory Specimens

NCT00999076 ·Status: TERMINATED

Nasal Swab Study to Explore the Nasal Microbia

NCT02535442 ·Status: COMPLETED

Trial of Antimycobacterial Therapy in Sarcoidosis

NCT01074554 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease

NCT01528930 ·Status: WITHDRAWN ·Phase: PHASE2

Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

NCT04677569 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia

NCT04320615 ·Status: COMPLETED ·Phase: PHASE3